Filgotinib: Ph II started

Gilead began a double-blind, placebo-controlled, international Phase II trial to evaluate oral 200 mg filgotinib, 30 mg oral GS-9876 or 40 mg oral tirabrutinib (GS-4059, ONO-4059) each alone once dail...